Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
暂无分享,去创建一个
M. Taniwaki | T. Komori | K. Ikawa | N. Morikawa | C. Shimazaki | K. Nomura | K. Ikeda | Y. Fujimoto | D. Shimizu | K. Taniguchi | K. Shimura | Y. Kanbayashi | Yosuke Matsumoto | N. Fujita